Blood sugar treatment may protect brain cells from Alzheimer's - Mirror Online: Alzheimer's disease could be cured by preventing low blood sugar in the brain, scientists revealed yesterday.
They experimented on mice using a chemical to maintain the supply of blood glucose to brain cells – and found it helped tostop dementia.
Chemical biologist Prof David Vocadlo and his team at the Simon Fraser University in Canada, genetically programmed mice to develop Alzheimer’s before injecting them with the chemical called Thiamet-G.
Wednesday, February 29, 2012
Walnuts May Boost Memory and Improve Cognitive Function: New Results from Landmark... -- FOLSOM, Calif., Feb. 29, 2012 /PRNewswire/ --
Walnuts May Boost Memory and Improve Cognitive Function: New Results from Landmark... -- FOLSOM, Calif., Feb. 29, 2012 /PRNewswire/ --: The study reported regular consumption of walnuts, but not of other nuts, was associated with better working memory. The investigators believe that the high polyphenol (antioxidant) content found in walnuts may be one of the key elements in helping to preserve cognition and fight age-related cognitive decline. Coffee, virgin olive oil and wine were also associated with better cognitive scores.
Monday, February 27, 2012
Anti-oxidant Therapy Presents a Promising Strategy in Prevention or Delaying the Onset and Progression of Alzheimer - seattlepi.com
Anti-oxidant Therapy Presents a Promising Strategy in Prevention or Delaying the Onset and Progression of Alzheimer - seattlepi.com: A newly published study, in Free Radical Biology and Medicine, provides direct evidence between increased oxidative damage and pathological responses in early memory deficits (pre-plaque) stage of Alzheimer Disease. Nutri-Med Logic Corp, agreeing with this study, adds that inadequate anti-oxidant defense is a precedent condition in Alzheimer, thus, highlighting the importance of an early anti-oxidant diet, as a therapeutic intervention. However, an early anti-inflammatory diet would be as important as the anti-oxidant diet.
Researchers test sugary solution to Alzheimer’s
Researchers test sugary solution to Alzheimer’s: Slowing or preventing the development of Alzheimer’s disease, a fatal brain condition expected to hit one in 85 people globally by 2050, may be as simple as ensuring a brain protein’s sugar levels are maintained.
Medical News:Reduced Omega-3 Speeds Brain Aging - in Neurology, Dementia from MedPage Today
Medical News:Reduced Omega-3 Speeds Brain Aging - in Neurology, Dementia from MedPage Today: Lower blood levels of omega-3 fatty acids are associated with smaller brain volumes and worse cognitive performance, researchers reported.
The structural findings suggest that people with low levels of the nutrients -- found mainly in fish -- have brains that appear to have aged faster than normal, according to Zaldy Tan, MD, of the University of California Los Angeles, and colleagues.
The structural findings suggest that people with low levels of the nutrients -- found mainly in fish -- have brains that appear to have aged faster than normal, according to Zaldy Tan, MD, of the University of California Los Angeles, and colleagues.
Thursday, February 23, 2012
foodconsumer.org - Red grape juice may help fight Alzheimer's disease
foodconsumer.org - Red grape juice may help fight Alzheimer's disease: Thursday Fed 22, 2012 (foodconsumer.org) -- A new study in Journal of Isfahan Medical School in Iran suggests that eating red grapes or drinking red grape juice regularly can help fight Alzheimer's disease.
Alzheimer's drug may impair memory | Fox News
Alzheimer's drug may impair memory Fox News: A class of drugs being investigated to treat Alzheimer's disease may actually have the opposite effect of the original intent — they may impair memory, a new study in animals suggests.
The drugs, known as BACE1 inhibitors, are designed to prevent the formation of the protein plaques in the brain that are a hallmark of Alzheimer's disease. However, the new study suggests these drugs interfere with the brain's wiring, potentially affecting the formation of new memories.
The drugs, known as BACE1 inhibitors, are designed to prevent the formation of the protein plaques in the brain that are a hallmark of Alzheimer's disease. However, the new study suggests these drugs interfere with the brain's wiring, potentially affecting the formation of new memories.
Alzheimer's Disease: Skin Cancer Drug Sparks Hope, Desperation - ABC News
Alzheimer's Disease: Skin Cancer Drug Sparks Hope, Desperation - ABC News: Because bexarotene is already approved by the U.S. Food and Drug Administration for skin cancer, doctors can legally prescribe it "off-label" for other conditions. But Alzheimer's experts urge families to temper their hope until the drug is proved safe and effective by years of clinical trials -- a tall order for the country's 5.4 million patients and 14.9 million caregivers.
Wednesday, February 22, 2012
Why I've created this blog.
My father, grandfather, and at least one uncle had Alzheimer’s. I’m not afraid of dying; but I am afraid of Alzheimer’s. You can find information about me in my first posting. Alzheimer’s is not my expertise; but I do know something about research and I keep up on the news. This is where you can find what appears to be credible research and news. Subscribe to the blog and become a follower to keep up on the latest information and news, both good and bad.
Both my father and grandfather and possibly an uncle died with alzheimer's. Please use this as a place for discussions and questions and answers.
Both my father and grandfather and possibly an uncle died with alzheimer's. Please use this as a place for discussions and questions and answers.
Friday, February 10, 2012
A Cancer Drug Reverses Alzheimer's Disease in Mice | Healthland | TIME.com
A Cancer Drug Reverses Alzheimer's Disease in Mice Healthland TIME.com: Researchers at Case Western Reserve University have discovered that a drug currently used to treat cancer patients can reverse the cognitive deficits related to Alzheimer’s disease in mice, and what’s more, it accomplishes this feat in a remarkably short period of time.
The drug, called bexarotene, has been approved for the treatment of a type of skin cancer since 1999. In the new experiments with genetically engineered mice, the drug quickly cleared away the beta-amyloid plaques in the brain that are believed to cause cognitive deficits in Alzheimer’s disease.
The drug, called bexarotene, has been approved for the treatment of a type of skin cancer since 1999. In the new experiments with genetically engineered mice, the drug quickly cleared away the beta-amyloid plaques in the brain that are believed to cause cognitive deficits in Alzheimer’s disease.
Subscribe to:
Posts (Atom)